XML 33 R19.htm IDEA: XBRL DOCUMENT
v3.7.0.1

Mandatorily Redeemable Series A Preferred Stock | 6 Months Ended
--- | ---
Jun. 30, 2017
Equity [Abstract] |
Mandatorily Redeemable Series A Preferred Stock | 13. Mandatorily Redeemable Series A Preferred Stock On September 13, 2011, the Company entered into a financing agreement with an investor (the “Series A Investor”). The agreement provided for the sale of Series A Preferred Stock (“Series A Preferred Stock”) to the Series A Investor in multiple tranches. As part of this agreement, the Series A Investor received 22 shares of Series A Preferred Stock with an issuance price of $1,000 per share as well as 14,300 shares of common stock in exchange for gross proceeds of $22,000 in September 2011. The second tranche of 26 shares of Series A Preferred Stock was issued in January 2012, in exchange for gross proceeds of $26,000. Dividends accrued and accumulated on the Series A Preferred Stock, whether or not earned or declared, at the rate of 15% per annum and compound quarterly on April 1, July 1, October 1 and January 1. Dividends were paid in-kind with additional Series A Preferred Stock; fractional share portions of calculated dividends were paid in cash. In-kind dividends were accounted for as interest expense and were accrued as part of the long-term liability in the consolidated balance sheets. The Company issued $0 and $2,714 Series A Preferred Stock for dividends in the six months ended June 30, 2017 and 2016, respectively. For the three months ended June 30, 2017 and 2016, the Company incurred $0 and $1,623 of interest expense related to the Preferred Shares, respectively. For the six months ended June 30, 2017 and 2016, the Company incurred $0 and $3,182 of interest expense related to the Series A Preferred Stock, respectively. Of this expense, $0 and $59 were capitalized into property, plant and equipment in the consolidated balance sheets as of June 30, 2017 and December 31, 2016, respectively. On November 9, 2016, the Series A Preferred Stock was fully redeemed at a total redemption value of $40,329 using a portion of the proceeds from the IPO.

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -URI http://asc.fasb.org/topic&trid=2208762 + Details
Name: | us-gaap_PreferredStockTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration